Medinol Revenue and Competitors
Estimated Revenue & Valuation
- Medinol's estimated annual revenue is currently $40.4M per year.
- Medinol's estimated revenue per employee is $251,000
Employee Data
- Medinol has 161 Employees.
- Medinol grew their employee count by 5% last year.
Medinol's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Regulatory Affairs | Reveal Email/Phone |
2 | VP Innovative Technologies | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | EVP Global Commercialization | Reveal Email/Phone |
5 | Head Quality Assurance | Reveal Email/Phone |
6 | Head Labs and Technical Services | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | HR Group Manager | Reveal Email/Phone |
9 | Program Manager | Reveal Email/Phone |
10 | Project Manager | Reveal Email/Phone |
Medinol Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $21.1M | 84 | 0% | N/A | N/A |
#2 | $5.6M | 45 | 0% | $91.1M | N/A |
#3 | $202.8M | 577 | -2% | $632.9M | N/A |
#4 | $21.3M | 85 | -29% | $99.9M | N/A |
#5 | $21.1M | 84 | 2% | $128M | N/A |
#6 | $22.3M | 89 | 1% | N/A | N/A |
#7 | $6.8M | 27 | -4% | N/A | N/A |
#8 | $5.8M | 23 | -12% | N/A | N/A |
#9 | $3.3M | 13 | 0% | N/A | N/A |
#10 | $1.3M | 5 | 0% | N/A | N/A |
What Is Medinol?
Medinol is dedicated to the science of cardiovascular intervention. For over 25 years, we have delivered over two million coronary stents to patients worldwide. Our products constantly stretch the limits of innovation and our cutting-edge technology continues to demonstrate extraordinary clinical results. We make our products in-house using proprietary manufacturing technologies that ensure consistently exceptional quality and safety. Medinol manufactures EluNIR™, the first elastomeric drug eluting stent. Now FDA approved and CE marked, EluNIR demonstrated excellent clinical outcomes and promising safety profile in two clinical studies and features the Flexx² catheter technology with a metallic spring-tip, resulting in unprecedented ease-of-delivery even in tough anatomies. A unique stent design provides low metal footprint and optimized vessel support, leveraged by an elastomeric coating that ensures excellent surface quality. Founded in 1992 by Dr. Judith Richter and Dr. Kobi Richter and privately held to this day, Medinol continues to benefit from the leadership and insight of its founders. With more than 300 employees on board, we proudly maintain our family spirit and entrepreneurial culture. Interested in joining Medinol ? Click the link below to visit our website
keywords:N/AN/A
Total Funding
161
Number of Employees
$40.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medinol News
... Terumo Corporation, Biosensors International Group Ltd., Abbott, Medtronic, Biotronik, Medinol Ltd., Cook, STENTYS SA.
The major players covered in Occlusion Catheters Markets: LeMaitre; ISO Med; Edwards Lifesciences; Medinol; Stryker; Arthesys; CooperSurgical...
... MicroPort Scientific Corporation, Terumo Corporation, Biosensors International Group Ltd., Abbott, Medtronic, Biotronik, Medinol Ltd., Cook, STENTYS SA.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $58.4M | 161 | 7% | N/A |
#2 | $43.9M | 163 | 1% | N/A |
#3 | $26.2M | 164 | 15% | N/A |
#4 | $59.3M | 166 | 27% | N/A |
#5 | $73.5M | 167 | 24% | N/A |